1 |
Ghobrial GM, Anderson KD, Dididze M, Martinez-Barrizonte J, Sunn GH, Gant KL, et al. : Human neural stem cell transplantation in chronic cervical spinal cord injury: functional outcomes at 12 months in a phase II clinical trial. Neurosurgery 64 (CN_suppl_1) : 87-91, 2017
DOI
|
2 |
Gonzalez F, Boue S, Izpisua Belmonte JC : Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat Rev Genet 12 : 231-242, 2011
DOI
|
3 |
Hejcl A, Sedy J, Kapcalova M, Toro DA, Amemori T, Lesny P, et al. : HPMA-RGD hydrogels seeded with mesenchymal stem cells improve functional outcome in chronic spinal cord injury. Stem Cells Dev 19 : 1535-1546, 2010
DOI
|
4 |
Hori J, Ng TF, Shatos M, Klassen H, Streilein JW, Young MJ : Neural progenitor cells lack immunogenicity and resist destruction as allografts. Stem Cells 21 : 405-416, 2003
DOI
|
5 |
Saito F, Nakatani T, Iwase M, Maeda Y, Murao Y, Suzuki Y, et al. : Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: a pilot study. Restor Neurol Neurosci 30 : 127-136, 2012
|
6 |
Seo DK, Kim JH, Min J, Yoon HH, Shin ES, Kim SW, et al. : Enhanced axonal regeneration by transplanted Wnt3a-secreting human mesenchymal stem cells in a rat model of spinal cord injury. Acta Neurochir (Wien) 159 : 947-957, 2017
DOI
|
7 |
Shin JC, Kim KN, Yoo J, Kim IS, Yun S, Lee H, et al. : Clinical trial of human fetal brain-derived neural stem/progenitor cell transplantation in patients with traumatic cervical spinal cord injury. Neural Plast 2015 : 630932, 2015
|
8 |
Hwang NS, Varghese S, Elisseeff J : Controlled differentiation of stem cells. Adv Drug Deliv Rev 60 : 199-214, 2008
DOI
|
9 |
Shrestha B, Coykendall K, Li Y, Moon A, Priyadarshani P, Yao L : Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res Ther 5 : 91, 2014
DOI
|
10 |
Hur JW, Cho TH, Park DH, Lee JB, Park JY, Chung YG : Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial. J Spinal Cord Med 39 : 655-664, 2016
DOI
|
11 |
Jeong JH, Lee JH, Jin ES, Min JK, Jeon SR, Choi KH : Regeneration of intervertebral discs in a rat disc degeneration model by implanted adipose-tissue-derived stromal cells. Acta Neurochir (Wien) 152 : 1771-1777, 2010
DOI
|
12 |
Tashiro S, Nishimura S, Iwai H, Sugai K, Zhang L, Shinozaki M, et al. : Functional recovery from neural stem/progenitor cell transplantation combined with treadmill training in mice with chronic spinal cord injury. Sci Rep 6 : 30898, 2016
DOI
|
13 |
Silva NA, Sousa N, Reis RL, Salgado AJ : From basics to clinical: a comprehensive review on spinal cord injury. Prog Neurobiol 114 : 25-57, 2014
DOI
|
14 |
Stenudd M, Sabelstrom H, Frisen J : Role of endogenous neural stem cells in spinal cord injury and repair. JAMA Neurol 72 : 235-237, 2015
DOI
|
15 |
Sykova E, Homola A, Mazanec R, Lachmann H, Konradova SL, Kobylka P, et al. : Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 15 : 675-687, 2006
DOI
|
16 |
Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, et al. : Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A 99 : 3024-3029, 2002
DOI
|
17 |
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K : Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24 : 1294-1301, 2006
DOI
|
18 |
Kanno H, Pearse DD, Ozawa H, Itoi E, Bunge MB : Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus. Rev Neurosci 26 : 121-128, 2015
DOI
|
19 |
Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H : Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neuros 114 : 935-939, 2012
DOI
|
20 |
Keilhoff G, Goihl A, Langnase K, Fansa H, Wolf G : Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol 85 : 11-24, 2006
DOI
|
21 |
Kishk NA, Gabr H, Hamdy S, Afifi L, Abokresha N, Mahmoud H, et al. : Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 24 : 702-708, 2010
DOI
|
22 |
Knoller N, Auerbach G, Fulga V, Zelig G, Attias J, Bakimer R, et al. : Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine 3 : 173-181, 2005
DOI
|
23 |
Ullah I, Subbarao RB, Rho GJ : Human mesenchymal stem cells - current trends and future prospective. Biosci Rep 35 : e00191, 2015
DOI
|
24 |
Al-Zoubi A, Jafar E, Jamous M, Al-Twal F, Al-Bakheet S, Zalloum M, et al. : Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy. Cell Transplant 23 Suppl 1 : S25-S34, 2014
|
25 |
Anderson KD, Guest JD, Dietrich WD, Bartlett Bunge M, Curiel R, Dididze M, et al. : Safety of autologous human schwann cell transplantation in subacute thoracic spinal cord injury. J Neurotrauma 34 : 2950-2963, 2017
DOI
|
26 |
Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, et al. : A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma 28 : 1611-1682, 2011
DOI
|
27 |
Trounson A, McDonald C : Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 17 : 11-22, 2015
DOI
|
28 |
Ubiali F, Nava S, Nessi V, Frigerio S, Parati E, Bernasconi P, et al. : Allorecognition of human neural stem cells by peripheral blood lymphocytes despite low expression of MHC molecules: role of in modulating proliferation. Int Immunol 19 : 1063-1074, 2007
DOI
|
29 |
Valverde F, Santacana M, Heredia M : Formation of an olfactory glomerulus: morphological aspects of development and organization. Neuroscience 49 : 255-275, 1992
DOI
|
30 |
Vaquero J, Zurita M, Rico MA, Bonilla C, Aguayo C, Montilla J, et al. : An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial. Cytotherapy 18 : 1025-1036, 2016
DOI
|
31 |
Wakao S, Matsuse D, Dezawa M : Mesenchymal stem cells as a source of Schwann cells: their anticipated use in peripheral nerve regeneration. Cells Tissues Organs 200 : 31-41, 2014
DOI
|
32 |
Xiao Z, Tang F, Zhao Y, Han G, Yin N, Li X, et al. : Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with neuroregen scaffolds and mesenchymal stem cells. Cell Transplant 27 : 907-915, 2018
DOI
|
33 |
Luo L, Albashari AA, Wang X, Jin L, Zhang Y, Zheng L, et al. : Effects of transplanted heparin-poloxamer hydrogel combining dental pulp stem cells and bFGF on spinal cord injury repair. Stem Cells Int 2018 : 2398521, 2018
|
34 |
Lee HY, Hong IS : Double-edged sword of mesenchymal stem cells: cancer-promoting versus therapeutic potential. Cancer Sci 108 : 1939-1946, 2017
DOI
|
35 |
Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD : Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J Spinal Cord Med 29 : 191-203; discussion 204-246, 2006
DOI
|
36 |
Lu P, Jones LL, Snyder EY, Tuszynski MH : Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181 : 115-129, 2003
DOI
|
37 |
Matsuse D, Kitada M, Kohama M, Nishikawa K, Makinoshima H, Wakao S, et al. : Human umbilical cord-derived mesenchymal stromal cells differentiate into functional Schwann cells that sustain peripheral nerve regeneration. J Neuropathol Exp Neurol 69 : 973-985, 2010
DOI
|
38 |
McDonough A, Martinez-Cerdeno V : Endogenous proliferation after spinal cord injury in animal models. Stem Cells Int 2012 : 387513, 2012
DOI
|
39 |
Mendonca MV, Larocca TF, de Freitas Souza BS, Villarreal CF, Silva LF, Matos AC, et al. : Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury. Stem Cell Res Ther 5 : 126, 2014
DOI
|
40 |
Min J, Kim JH, Choi KH, Yoon HH, Jeon SR : Is there additive therapeutic effect when GCSF combined with adipose-derived stem cell in a rat model of acute spinal cord injury? J Korean Neurosurg Soc 60 : 404-416, 2017
DOI
|
41 |
Ding DC, Chang YH, Shyu WC, Lin SZ : Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant 24 : 339-347, 2015
DOI
|
42 |
Yao R, Murtaza M, Velasquez JT, Todorovic M, Rayfield A, Ekberg J, et al. : Olfactory ensheathing cells for spinal cord injury: sniffing out the issues. Cell Transplant 27 : 879-889, 2018
DOI
|
43 |
Mothe AJ, Tator CH : Review of transplantation of neural stem/progenitor cells for spinal cord injury. Int J Dev Neurosci 31 : 701-713, 2013
DOI
|
44 |
Arnhold S, Klein H, Semkova I, Addicks K, Schraermeyer U : Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 45 : 4251-4255, 2004
DOI
|
45 |
Bhanot Y, Rao S, Ghosh D, Balaraju S, Radhika CR, Satish Kumar KV : Autologous mesenchymal stem cells in chronic spinal cord injury. Br J Neurosurg 25 : 516-522, 2011
DOI
|
46 |
Bozkurt G, Mothe AJ, Zahir T, Kim H, Shoichet MS, Tator CH : Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery 67 : 1733-1744, 2010
DOI
|
47 |
Chen BK, Madigan NN, Hakim JS, Dadsetan M, McMahon SS, Yaszemski MJ, et al. : GDNF Schwann cells in hydrogel scaffolds promote regional axon regeneration, remyelination and functional improvement after spinal cord transection in rats. J Tissue Eng Regen Med 12 : e398-e407, 2018
DOI
|
48 |
Christodoulou I, Goulielmaki M, Devetzi M, Panagiotidis M, Koliakos G, Zoumpourlis V : Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review. Stem Cell Res Ther 9 : 336, 2018
DOI
|
49 |
Deda H, Inci MC, Kurekci AE, Kayihan K, Ozgun E, Ustunsoy GE, et al. : Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year followup. Cytotherapy 10 : 565-574, 2008
DOI
|
50 |
di Summa PG, Kingham PJ, Raffoul W, Wiberg M, Terenghi G, Kalbermatten DF : Adipose-derived stem cells enhance peripheral nerve regeneration. J Plast Reconstr Aesthet Surg 63 : 1544-1552, 2010
DOI
|
51 |
Yoon HH, Min J, Shin N, Kim YH, Kim JM, Hwang YS, et al. : Are human dental papilla-derived stem cell and human brain-derived neural stem cell transplantations suitable for treatment of Parkinson's disease? Neural Regen Res 8 : 1190-1200, 2013
|
52 |
Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, et al. : Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 25 : 2066-2073, 2007
DOI
|
53 |
Young W : Electrical stimulation and motor recovery. Cell Transplant 24 : 429-446, 2015
DOI
|
54 |
Zeng X, Zeng YS, Ma YH, Lu LY, Du BL, Zhang W, et al. : Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury. Cell Transplant 20 : 1881-1899, 2011
DOI
|
55 |
Zhu H, Poon W, Liu Y, Leung GK, Wong Y, Feng Y, et al. : Phase I-II clinical trial assessing safety and efficacy of umbilical cord blood mononuclear cell transplant therapy of chronic complete spinal cord injury. Cell Transplant 25 : 1925-1943, 2016
DOI
|
56 |
Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH, et al. : Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng 11 : 913-922, 2005
DOI
|
57 |
Oh SK, Choi KH, Yoo JY, Kim DY, Kim SJ, Jeon SR : A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury. Neurosurgery 78 : 436-447; discussion 447, 2016
DOI
|
58 |
Okada S, Ishii K, Yamane J, Iwanami A, Ikegami T, Katoh H, et al. : In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J 19 : 1839-1841, 2005
DOI
|
59 |
Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, et al. : Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 11 : 897-911, 2009
DOI
|
60 |
Park JH, Kim DY, Sung IY, Choi GH, Jeon MH, Kim KK, et al. : Longterm results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 70 : 1238-1247; discussion 1247, 2012
DOI
|
61 |
Geffner LF, Santacruz P, Izurieta M, Flor L, Maldonado B, Auad AH, et al. : Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 17 : 1277-1293, 2008
DOI
|
62 |
Ziv Y, Avidan H, Pluchino S, Martino G, Schwartz M : Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A 103 : 13174-13179, 2006
DOI
|
63 |
Park JH, Min J, Baek SR, Kim SW, Kwon IK, Jeon SR : Enhanced neuroregenerative effects by scaffold for the treatment of a rat spinal cord injury with Wnt3a-secreting fibroblasts. Acta Neurochir (Wien) 155 : 809-816, 2013
DOI
|
64 |
Parr AM, Tator CH, Keating A : Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant 40 : 609-619, 2007
DOI
|
65 |
Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, Emami-Razavi SH, et al. : Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 443 : 46-50, 2008
DOI
|
66 |
Dlouhy BJ, Awe O, Rao RC, Kirby PA, Hitchon PW : Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: case report. J Neurosurg Spine 21 : 618-622, 2014
DOI
|
67 |
Fawcett JW, Curt A, Steeves JD, Coleman WP, Tuszynski MH, Lammertse D, et al. : Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 45 : 190-205, 2007
DOI
|
68 |
Gage FH : Mammalian neural stem cells. Science 287 : 1433-1438, 2000
DOI
|